Navigation Links
Miracle Treatment for Burn Scars as Seen on Today Show Will Also Be Featured on The Insider Tonight
Date:5/28/2009

NEW YORK, May 28 /PRNewswire/ -- Following the feature of the UltraPulse CO2 fractional laser as a Miracle Treatment for Burn Scars on The Today Show, The Insider will also be featuring the treatment tonight, check your local listings for the time.

Chandra, Jordan and Trae Berns were interviewed today by The Insider. The interview focused on how and when they got their burns they have lived with for 20 years. The girls also discussed their journey through the treatment process with Dr. Jill Waibel, the treating physician. Specifically, they discussed how the Lumenis UltraPulse Laser has helped to minimize both the unwanted color and roughness of their scars. Lastly, they expressed their happiness in the results of the treatments thus far and look forward to additional treatments and results in the next 3 months.

Dr. Jill Waibel was also interviewed for the segment, in which she discussed the fractional treatment she performed on the girls using the Lumenis laser. Specifically, Dr. Waibel talked about the TotalFX, ActiveFX and DeepFX treatments that were used on the girl's burn scars.

Lumenis pioneered skin resurfacing over 18 years ago with its C02 lasers. The Lumenis UltraPulse laser system has FDA clearance for more than 34 indications and is referenced in excess of 90 peer-reviewed publications. Although frequently used for aesthetic applications, the UltraPulse offers 240 watts of power and microsecond pulses which combined provide a broad canvas from which other treatments in cutaneous surgical and aesthetic applications can be provided.

The entire story of the Berns triplets and their treatments using the UltraPulse Fractional CO2 laser can be found at www.bernstriplets.com.

About Lumenis

Lumenis Ltd,. a global developer, manufacturer and seller of laser, light-based and radiofrequency devices for surgical, aesthetic, and ophthalmic applications, is Israel's largest medical device company with more than 800 employees worldwide. The Company invests heavily in R&D and holds a leading position in the markets in which it serves. Lumenis has over 250 patents worldwide, over 75 FDA clearances, worldwide presence in over 100 countries, and an installed base of over 70,000 systems. For more information about Lumenis and its products, log onto www.lumenis.com.

    Contacts: Charly Rok                  Michelle Maydan
              Lippe Taylor                Director of Corporate Communications
              Office: 212-598-4400 x155   Lumenis
              Cell:  917-912-2863         Toll-free: 1-866-569-0597
              charly@lippetaylor.com      Office: +972-4-959-9004
                                          mmaydan@lumenis.com

Lumenis(R) is a registered trademark of Lumenis Ltd.

UltraPulse(R) is a trademark of Lumenis Ltd.

Certain statements and information in this press release may be deemed to be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, statements that contain projections of results of operations or of financial condition and all statements (other than statements of historical facts) that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. Forward-looking statements are often characterized by the use of forward-looking terminology such as "may," "will," "expect," "anticipate," "estimate," "continue," "believe," "should," "intend," "project" or other similar words, but are not the only way these statements are identified. We have based these forward-looking statements on assumptions and assessments made by our management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any forward-looking statements in this press release are made as of the date hereof, and we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments and business decisions to differ materially from those anticipated in these forward-looking statements may be found in our most recent Annual Report on Form 20-F, including the section therein entitled "Risk Factors", as well in our reports on Form 6-K, filed with the Securities and Exchange Commission.


'/>"/>
SOURCE Lumenis Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Ferring Announces $10,000 Grand Prize Winner of 2007 My Little Miracle Essay Contest
2. Childrens Miracle Network Hospital Doctors On Call to Answer Questions About MRSA Infection
3. Worlds Miracle Baby Turns One
4. Sharing Miracles Television Program Extends Reach Across America: First Episode Features Former White House Press Secretary Tony Snow
5. Round Table Family Charities Raises $350,000 for Childrens Miracle Network
6. Cranberries really are a miracle cure for women
7. Sharing Miracles Television Program to Feature North Carolina State Womens Basketball Coach Kay Yow
8. Sharing Miracles Television Program to Feature Mountain Climber and Cancer Survivor Sean Swarner
9. Sharing Miracles Television Program to Feature Emmy Award-Winning Actor Joey Pantoliano
10. Press Preview to Unveil Miracle Manny
11. The Miracle of Funding by State and Local Pension Plans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... ... Agile Software Development, has been awarded a contract by the Center for Medicare ... (BPA) aims to accelerate the enterprise use of Agile methodologies in a consistent ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are ... cessation in breathing. Oral appliances can offer significant relief to about 75 percent ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics ... PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s ... of Morris F. Collen, a pioneer in the field of medical informatics, this prestigious ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in ... 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced ... 2017. , The annual award competition recognizes editorial and design excellence across a range ...
(Date:10/12/2017)... ... 2017 , ... Health Literacy Innovations (HLI), creator of the ... the Cancer Patient Education Network (CPEN), an independent professional organization that shares best ... alliance. , As CPEN’s strategic partner, HLI will help support CPEN members ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... , Sept. 28, 2017 Cohen Veterans Bioscience ... the use of wearable and home sensors for real-time ... Early Signal Foundation, a nonprofit organization focused on disruptive ... provide an affordable analytical system to record and integrate ... ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., a ... design, and immune-engineering today announced the launch of ... development of personalized therapeutic cancer vaccines. EpiVax has ... exclusive access to enabling technologies to the new ... will lead EpiVax Oncology as Chief Executive Officer. ...
(Date:9/19/2017)... Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company ... destruction of targeted tissues, announced three leadership team developments today:   ... PhD ... ... Veteran medical device executive Josh ...
Breaking Medicine Technology: